Several risk scores have been designed for this purpose (eg, TIMI [Thrombolysis in Myocardial Infarction], GRACE [Global Registry of Acute Coronary Events], HEART [History, ECG, Age, Risk factors and ...

Myocardial perfusion imaging (MPI) is an important imaging modality in the management of patients with cardiovascular disease. MPI plays a key role in diagnosing cardiovascular disease, establishing ...

Patients with myocardial infarction in the nonsurgical setting typically have ischemic symptoms that fulfill a key diagnostic criterion. 6 However, perioperative sedation or analgesia can mask ...

Type 2 myocardial infarction is caused by myocardial blood flow supply/demand imbalance leading to ischaemia and eventually, myocardial necrosis. The imbalance is triggered by other conditions than a ...

Objective Acute myocardial infarction (AMI) is the leading cause of death and disability globally. There is increasing evidence from observational studies that influenza infection is associated with ...

Oxygen (O2) is widely recommended in international guidelines for treatment of acute myocardial infarction (AMI), but there is uncertainty about its safety and benefits. A systematic review and ...

Ginsenoside Rh2 (Rh2), an important phytochemical derived from Panax ginseng, has demonstrated anticancer activity, amelioration of ischemic brain injury, and mitigation of doxorubicin-induced cardiac ...

Ozturk MA, Ozveren O, Cinar V, Erdik B, and Oyan B. Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood coagulation fibrinolysis an Int J ...

Objective Compare survival in patients with ST-elevation myocardial infarction (STEMI) treated with a pharmacoinvasive (PI) or primary percutaneous coronary intervention (pPCI) strategy based on ...

Myocardial infarction (MI) is the myocardial necrosis caused by persistent ischemia and hypoxia of coronary arteries. People do not realize that they are suffering from MI until they have a heart ...